Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Christopher D. Buckley, Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, Brandon Becker, Katherine Davy, Elena Fisheleva, Anubha Gupta, Carol Hawkes, David R. Inman, Mark Layton, Nina Mitchell, Jatin Patel, Didier Saurigny, R. Williamson, Paul P. Tak